Abstract
For the first time in a decade, both the number of candidates added to the waiting list and the number of lung transplants performed decreased from the year prior; the number of lung donors also declined. This slowing of transplant activities in 2020 was associated with a modest increase in waitlist mortality. The year 2020 was notable for the global outbreak of the COVID-19 pandemic, which undoubtedly influenced all trends noted in lung transplantation. Time to transplant continued to decrease, with a median time to transplant of 1.4 months across all waitlist candidates. Posttransplant survival remained stable, with 89.4% of transplant recipients surviving to 1 year, 74.8% to 3 years, and 61.2% to 5 years.
Original language | English (US) |
---|---|
Pages (from-to) | 438-518 |
Number of pages | 81 |
Journal | American Journal of Transplantation |
Volume | 22 |
Issue number | S2 |
DOIs | |
State | Published - Mar 2022 |
Bibliographical note
Publisher Copyright:© John Wiley & Sons, Ltd.
Keywords
- End-stage lung disease
- LAS
- lung allocation score
- lung transplant
- organ allocation
- revised lung allocation score
- transplant outcomes